Molecular Diagnostics
POCT Immunoassay Reader Provides Quantitative Analysis of Test Kits for More Accurate Diagnosis
A small, light-weight quantitative immunoassay reader that provides a quantitative analysis of any kind of rapid test kits or strips, and can be connected to a PC or laptop, smartphone or tablet, offers a reliable, convenient and affordable POCT solution for accurate disease diagnosis. More...12 Dec 2022
World’s First Rapid Saliva-Based Pregnancy Test Eliminates Need for Blood and Urine Samples
Salistick from Salignostics (Jerusalem, Israel) is the first rapid saliva-based pregnancy test for early and highly accurate pregnancy detection that does not require urine. The kit is based on the company’s revolutionary technology which detects the pregnancy hormone β-hCG in saliva from the first day of the missed period. More...09 Dec 2022
Cepheid's Multi-Target Test Design Enables Detection of Influenza Variants
Cepheid’s (Sunnyvale, CA, USA) respiratory test design enables detection of the currently circulating mutant strains of influenza, and with similar symptoms across various illnesses such as the flu, respiratory syncytial virus (RSV) disease, and COVID-19, when accurate and fast diagnosis is critical to patient care. More...09 Dec 2022
Portable UTI Molecular Diagnostic Platform Provides Accurate Test Results in 40 Minutes
The absence of fast diagnostic testing for Urinary Tract Infections (UTIs) means clinicians make treatment decisions based on vague clinical symptoms or inaccurate urine dipstick tests. Now, a rapid and affordable point-of-care molecular diagnostics platform developed specifically to detect bacterial and viral infections aims to change that. More...09 Dec 2022
New Blood Test Detects ‘Toxic’ Protein Years Before Alzheimer’s Symptoms Emerge
Researchers have developed a laboratory test that can measure the levels of amyloid beta oligomers in blood samples. The test could detect signs of Alzheimer's disease before cognitive impairment happens. More...07 Dec 2022
Biomarkers Predict Lyme Disease Post-Treatment Prognosis
Testing and diagnosis of the earliest stages of Lyme Disease (LD) have proven to be difficult or unreliable. The universally accepted diagnostic test for LD is a positive enzyme-linked immunosorbent assay (ELISA) followed by a positive western blot for immunoglobulin M (IgM) and IgG. More...06 Dec 2022
Low Cost, Highly Sensitive Blood Test for Cancer Makes Regular Monitoring Affordable
Scientists have discovered a novel low-cost method of testing for cancers. Called the Heatrich-BS assay, the new test sequences clinical samples that have been heated in order to isolate cancer-specific signatures found in a patient’s blood. More...06 Dec 2022
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Gel Cards
DG Gel Cards
New
Gold Member
Automatic CLIA Analyzer
Shine i9000
In Other News
New All-In-One Molecular Diagnostic System Realizes True Sample In -Result Out Detection Process
Method Enables Targeted Profiling of Human Extrachromosomal DNA
ctDNA-Based MRD Test to Detect As Few As One Mutant Molecule in a Million DNA Molecules
Study Identifies Optimal Blood Tests for Detection and Treatment of Early Stage Alzheimer’s
Blood Test for Protein Biomarker Could Detect Pancreatic Cancer at Very Early Stage
Blood Tests Could Predict Survival Odds for Patients with Metastatic Cancer
New Serological Test Could Search for Viral Triggers of Diseases
Blood-Based NIPS Test Improves Access to Genetic Testing
Two Tau Variants Distinguish Corticobasal Degeneration from Other Tauopathies
First-Ever Blood Test Could Detect Deadly Heart Inflammation Within Hours
Urine-Based, Non-Invasive Molecular Test Accurately Detects Bladder Cancer
Altered Ratios of p53 Isoforms Predict Response of Breast Tumors to Chemotherapy
Benchtop Immunoanalyzer Delivers Lab Quality Results for Cardiology, Intensive Care and Emergency Wards at POC
Blood Test Could Screen for Changes in Proteins Prior to Breast Cancer Diagnosis
Tumor Biopsies Analysis Performed on Newly-diagnosed B-cell Neoplasms
Acute COVID-19 Infections Are Characterized by Elevated Blood Levels of IL-26
New Tool Assesses Cost of ctDNA Testing
Multiplex Vaginal Panel Identifies Three Distinct Conditions in One Hour
Novel Assay Enables Simultaneous Detection of SMA and SCID in Newborns
Simple Blood Test Could More Than Double Liver Cancer Detection Rate in High-Risk Population
First-Ever Saliva-Based Concussion Test to Be Available in 2023
AI Blood Test Detects Liver Cancer
Non-Invasive Saliva Test Predicts Future Risk for Alzheimer's
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
